ASGCT'S MISSION IS TO ADVANCE KNOWLEDGE, AWARENESS, AND EDUCATION LEADING TO THE DISCOVERY AND CLINICAL APPLICATION OF GENETIC AND CELLULAR THERAPIES TO ALLEVIATE HUMAN DISEASE.
Executive compensation, broken down
Form 990 · Schedule J · 6 reported individuals · Filing year 2024
| Base salary | Bonus | Other compensation | Benefits | Executive compensation | |
|---|---|---|---|---|---|
Employee highest compensated employee $250k $269k | |||||
Employee highest compensated employee $231k $249k | |||||
Employee highest compensated employee $185k $199k | |||||
Employee highest compensated employee $173k $186k | |||||
Employee highest compensated employee $163k $176k | |||||
Teal figures restate each filed amount in 2026 dollars.
Estimated with BLS CPI-U for the Midwest region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Plus 19 unpaid individuals.
Up 32%
from 2023
From $469k in 2023 to $618k in 2024.
Estimated with BLS CPI-U for the Midwest region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Revenue and expenses over time
THE AMERICAN SOCIETY OF GENE & CELL THERAPY reported revenue and expenses across 2 filing years.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.